M
Mao Yang
Researcher at St. Jude Children's Research Hospital
Publications - 17
Citations - 2031
Mao Yang is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Autophagy & Biology. The author has an hindex of 10, co-authored 12 publications receiving 1338 citations.
Papers
More filters
Journal ArticleDOI
ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences
Yi-Nan Gong,Cliff Guy,Hannes Olauson,Jan U. Becker,Mao Yang,Patrick Fitzgerald,Andreas Linkermann,Douglas R. Green +7 more
TL;DR: It is shown that, during necroptosis, MLKL-dependent calcium (Ca2+) influx and phosphatidylserine (PS) exposure on the outer leaflet of the plasma membrane preceded loss of PM integrity.
Journal ArticleDOI
Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells
Jennifer Martinez,Larissa D. Cunha,Sunmin Park,Mao Yang,Qun Lu,Robert C. Orchard,Quan Zhen Li,Mei Yan,Laura J. Janke,Cliff Guy,Andreas Linkermann,Herbert W. Virgin,Douglas R. Green +12 more
TL;DR: In this paper, the authors describe the consequences of defective LC3-associated phagocytosis in vivo and show that mice lacking any of several components of the LAP pathway show increased serum levels of inflammatory cytokines and autoantibodies, glomerular immune complex deposition, and evidence of kidney damage.
Journal ArticleDOI
LC3-associated endocytosis facilitates β-amyloid clearance and mitigates neurodegeneration in murine Alzheimer’s Disease
Bradlee L. Heckmann,Brett J. W. Teubner,Bart Tummers,Emilio Boada-Romero,Lacie Harris,Mao Yang,Clifford S. Guy,Stanislav S. Zakharenko,Douglas R. Green +8 more
TL;DR: The data support a protective role for LANDO in microglia in neurodegenerative pathologies resulting from β-amyloid deposition, and identify a novel non-canonical function of several autophagy proteins in the conjugation of LC3 to Rab5+, clathrin+ endosomes containing β-amide.
Journal ArticleDOI
LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance.
Larissa D. Cunha,Mao Yang,Robert Carter,Clifford S. Guy,Lacie Harris,Jeremy Chase Crawford,Giovanni Quarato,Emilio Boada-Romero,Halime Kalkavan,Michael D. L. Johnson,Sivaraman Natarajan,Meghan E. Turnis,David Finkelstein,Joseph T. Opferman,Charles Gawad,Douglas R. Green +15 more
TL;DR: It is found that the anti-tumor effects of LAP impairment require tumor-infiltrating T cells, dependent upon STING and the type I interferon response, and autophagy proteins in the myeloid cells of the tumor microenvironment contribute to immune suppression of T lymphocytes by effecting LAP.
Journal ArticleDOI
BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation.
Fabien Llambi,Yue-Ming Wang,Bernadette Victor,Mao Yang,Desiree M. Schneider,Sebastien Gingras,Melissa J. Parsons,Janet H. Zheng,Scott A. Brown,Stephane Pelletier,Tudor Moldoveanu,Taosheng Chen,Douglas R. Green +12 more
TL;DR: BOK is a bona fide yet unconventional effector of MOMP that can trigger apoptosis in the absence of both BAX and BAK, but unlike the canonical effectors, BOK appears to be constitutively active and unresponsive to antagonistic effects of the antiapoptotic BCL-2 proteins.